These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15070911)

  • 1. Efficacy of recombinant methionyl human leptin therapy for the extreme insulin resistance of the Rabson-Mendenhall syndrome.
    Cochran E; Young JR; Sebring N; DePaoli A; Oral EA; Gorden P
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1548-54. PubMed ID: 15070911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy.
    Lee JH; Chan JL; Sourlas E; Raptopoulos V; Mantzoros CS
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2605-11. PubMed ID: 16636130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy of leptin replacement in patients with generalized lipodystrophy.
    Javor ED; Cochran EK; Musso C; Young JR; Depaoli AM; Gorden P
    Diabetes; 2005 Jul; 54(7):1994-2002. PubMed ID: 15983199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptin therapy for partial lipodystrophy linked to a PPAR-gamma mutation.
    Guettier JM; Park JY; Cochran EK; Poitou C; Basdevant A; Meier M; Clément K; Magré J; Gorden P
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):547-554. PubMed ID: 18076675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients.
    Musso C; Cochran E; Javor E; Young J; Depaoli AM; Gorden P
    Metabolism; 2005 Feb; 54(2):255-63. PubMed ID: 15690321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in insulin sensitivity during leptin replacement therapy in leptin-deficient patients.
    Paz-Filho G; Esposito K; Hurwitz B; Sharma A; Dong C; Andreev V; Delibasi T; Erol H; Ayala A; Wong ML; Licinio J
    Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1401-8. PubMed ID: 18854428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes): a 30-year prospective.
    Musso C; Cochran E; Moran SA; Skarulis MC; Oral EA; Taylor S; Gorden P
    Medicine (Baltimore); 2004 Jul; 83(4):209-222. PubMed ID: 15232309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 1 diabetes associated with acquired generalized lipodystrophy and insulin resistance: the effect of long-term leptin therapy.
    Park JY; Chong AY; Cochran EK; Kleiner DE; Haller MJ; Schatz DA; Gorden P
    J Clin Endocrinol Metab; 2008 Jan; 93(1):26-31. PubMed ID: 17940115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy.
    Javor ED; Ghany MG; Cochran EK; Oral EA; DePaoli AM; Premkumar A; Kleiner DE; Gorden P
    Hepatology; 2005 Apr; 41(4):753-60. PubMed ID: 15791619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic use of recombinant methionyl human leptin.
    Vatier C; Gautier JF; Vigouroux C
    Biochimie; 2012 Oct; 94(10):2116-25. PubMed ID: 22464954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year metreleptin improves insulin secretion in patients with diabetes linked to genetic lipodystrophic syndromes.
    Vatier C; Fetita S; Boudou P; Tchankou C; Deville L; Riveline J; Young J; Mathivon L; Travert F; Morin D; Cahen J; Lascols O; Andreelli F; Reznik Y; Mongeois E; Madelaine I; Vantyghem M; Gautier J; Vigouroux C
    Diabetes Obes Metab; 2016 Jul; 18(7):693-7. PubMed ID: 26584826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive decline in insulin levels in Rabson-Mendenhall syndrome.
    Longo N; Wang Y; Pasquali M
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2623-9. PubMed ID: 10443650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin replacement improves postprandial glycemia and insulin sensitivity in human immunodeficiency virus-infected lipoatrophic men treated with pioglitazone: a pilot study.
    Magkos F; Brennan A; Sweeney L; Kang ES; Doweiko J; Karchmer AW; Mantzoros CS
    Metabolism; 2011 Jul; 60(7):1045-9. PubMed ID: 21081243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin-replacement therapy for lipodystrophy.
    Oral EA; Simha V; Ruiz E; Andewelt A; Premkumar A; Snell P; Wagner AJ; DePaoli AM; Reitman ML; Taylor SI; Gorden P; Garg A
    N Engl J Med; 2002 Feb; 346(8):570-8. PubMed ID: 11856796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Effects of Metreleptin in Rabson-Mendenhall Syndrome on Glycemia, Growth, and Kidney Function.
    Okawa MC; Cochran E; Lightbourne M; Brown RJ
    J Clin Endocrinol Metab; 2022 Feb; 107(3):e1032-e1046. PubMed ID: 34718628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metreleptin improves blood glucose in patients with insulin receptor mutations.
    Brown RJ; Cochran E; Gorden P
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1749-56. PubMed ID: 23969187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of efficacy and safety of leptin replacement therapy in moderately and severely hypoleptinemic patients with familial partial lipodystrophy of the Dunnigan variety.
    Simha V; Subramanyam L; Szczepaniak L; Quittner C; Adams-Huet B; Snell P; Garg A
    J Clin Endocrinol Metab; 2012 Mar; 97(3):785-92. PubMed ID: 22170723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of leptin replacement on pituitary hormone regulation in patients with severe lipodystrophy.
    Oral EA; Ruiz E; Andewelt A; Sebring N; Wagner AJ; Depaoli AM; Gorden P
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3110-7. PubMed ID: 12107209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy.
    Park JY; Javor ED; Cochran EK; DePaoli AM; Gorden P
    Metabolism; 2007 Apr; 56(4):508-16. PubMed ID: 17379009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.